We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.91B
AUM Growth
-$322M
Cap. Flow
-$466M
Cap. Flow %
-16.01%
Top 10 Hldgs %
16.3%
Holding
266
New
11
Increased
65
Reduced
149
Closed
26

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$18M
2
LDRH
LDR HOLDINGS CORP COM STK
LDRH
+$13.5M
3
TWOU
2U Inc
TWOU
+$13.2M
4
DWRE
DEMANDWARE INC COM STK (DE)
DWRE
+$12.2M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$11.4M

Top Sells

Rank Stock Value
1
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$33.5M
2
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
+$32.1M
3
CROX icon
Crocs
CROX
+$20.8M
4
FIVE icon
Five Below
FIVE
+$18.1M
5
BRKR icon
Bruker
BRKR
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 33.61%
2 Healthcare 20.94%
3 Industrials 10.75%
4 Financials 6.48%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRX
251
DELISTED
Chimerix, Inc.
CMRX
– –
-7,694
Closed -$294K
CHUY
252
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
– –
-272,274
Closed -$7.73M
IMGN
253
DELISTED
Immunogen Inc
IMGN
– –
-401,000
Closed -$3.85M
PTLA
254
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-79,710
Closed -$3.4M
AVEO
255
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-65,655
Closed -$794K
SPA
256
DELISTED
Sparton
SPA
– –
-61,527
Closed -$1.32M
SCMP
257
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
– –
-1,614,074
Closed -$32.1M
BRCD
258
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
– –
-398,500
Closed -$4.14M
BSTG
259
DELISTED
Biostage, Inc. Common Stock
BSTG
– –
-187,515
Closed -$159K
ADPT
260
DELISTED
Adeptus Health Inc
ADPT
– –
-127,823
Closed -$10.3M
COSI
261
DELISTED
COSI INC NEW COM STK (DE)
COSI
– –
-267,350
Closed -$273K
NSPH
262
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-125,429
Closed -$211K
RENT
263
DELISTED
RENTRAK CORP
RENT
– –
-115,421
Closed -$6.24M
YDLE
264
DELISTED
YODLEE INC COMMON STOCK
YDLE
– –
-575,442
Closed -$9.28M
AIRM
265
DELISTED
Air Methods Corp
AIRM
– –
-27,576
Closed -$940K
7 8 9 10
11

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return

Granahan Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Granahan Investment Management held 266 positions worth $2.91B, down 10% from $3.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management withdrew a net $466M in Q4 2015, closing 26 positions and reducing 149 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $33.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in Ionis Pharmaceuticals worth $13.1M.

  • Granahan Investment Management's largest Q4 2015 buy was Ionis Pharmaceuticals: 212,000 shares worth $13.1M.
  • Granahan Investment Management added most to Abiomed Inc in Q4 2015, an estimated $18M increase.
  • Granahan Investment Management's biggest Q4 2015 reduction was Crocs, cutting an estimated $20.8M.
  • Granahan Investment Management fully exited iShares Russell 2000 Growth ETF in Q4 2015, selling an estimated $33.5M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $2.91B portfolio in Q4 2015.
  • Granahan Investment Management opened 11 new positions and closed 26 in Q4 2015.
  • Granahan Investment Management's portfolio value fell 10% quarter-over-quarter to $2.91B.

Based on Granahan Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.